Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emile Darai"'
Autor:
Lea Ebanga, Yohann Dabi, Jeremie Benichou, Gregoire Miailhe, Kamila Kolanska, Jennifer Uzan, Clement Ferrier, Sofiane Bendifallah, Bassam Haddad, Emile Darai, Cyril Touboul
Publikováno v:
Journal of Investigative Surgery
Journal of Investigative Surgery, Informa Healthcare, 2022, 35 (6), pp.1386-1391. ⟨10.1080/08941939.2022.2045395⟩
Journal of Investigative Surgery, Informa Healthcare, 2022, 35 (6), pp.1386-1391. ⟨10.1080/08941939.2022.2045395⟩
International audience; Objective: The objective of our study was to determine the main surgical factors associated with postoperative pains in patients undergoing adnexectomy. Material and Methods: Patients that underwent adnexectomy in two French G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028f9cdc774dbb837fa020ec49bf6ccd
https://hal.sorbonne-universite.fr/hal-03683436/document
https://hal.sorbonne-universite.fr/hal-03683436/document
Autor:
Anne Puchar, Marie Despierres, Anne-Sophie Boudy, Lise Selleret, Joseph Gligorov, Sandrine Richard, Sonia Zilberman, Clément Ferrier, Yohann Dabi, Valentin Varlas, Isabelle Thomassin-Naggara, Sofiane Bendifallah, Cyril Touboul, Emile Darai
Publikováno v:
Breast
Breast, 2022, 61, pp.168-174. ⟨10.1016/j.breast.2022.01.004⟩
Breast, Vol 61, Iss, Pp 168-174 (2022)
The Breast : Official Journal of the European Society of Mastology
Breast, 2022, 61, pp.168-174. ⟨10.1016/j.breast.2022.01.004⟩
Breast, Vol 61, Iss, Pp 168-174 (2022)
The Breast : Official Journal of the European Society of Mastology
Introduction Triple-negative (TN) breast cancer represents one third of pregnancy-associated breast cancers (PABC). The aims of the current study were to describe oncological and obstetrical outcomes of patients with TN-PABC and to compare their prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9c294d17bd9d6b274e3e3f78e4df6e
https://hal.sorbonne-universite.fr/hal-03534729
https://hal.sorbonne-universite.fr/hal-03534729
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, Philippe Gabelle, Julia Pernaut, Francesco Del Piano, Gauthier D’Halluin, Stéphane Lantheaume, Emile Darai, Bassoodéo Beedassy, Caroline Dhainaut-Speyer, Xavier Martin, Sophie Girard, Richard Villet, Emilie Monrigal, Théophile Hoyek, Jean-François Le Brun, Pierre-Emmanuel Colombo, Agnès Tallet, Jean-Marie Boher, SERC trial group
Publikováno v:
npj Breast Cancer
npj Breast Cancer, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
npj Breast Cancer, Nature, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
NPJ Breast Cancer
npj Breast Cancer, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
npj Breast Cancer, Nature, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
NPJ Breast Cancer
Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or macro-metastases. However, there were limitations despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7778cc48965295aea1e88ef37dd72b
https://hal.sorbonne-universite.fr/hal-03406273
https://hal.sorbonne-universite.fr/hal-03406273
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Christine Tunon de Lara, Pierre Gimbergues, Tristan Gauthier, Christelle Faure-Virelizier, Véronique Vaini-Cowen, Stéphane Lantheaume, Claudia Regis, Emile Darai, Vivien Ceccato, Gauthier D’Halluin, Francesco Del Piano, Richard Villet, Eva Jouve, Bassoodéo Beedassy, Pierrick Theret, Philippe Gabelle, Cécile Zinzindohoue, Pierre Opinel, Catherine Marsollier-Ferrer, Caroline Dhainaut-Speyer, Pierre-Emmanuel Colombo, Eric Lambaudie, Agnès Tallet, Jean-Marie Boher, Others investigators (SERC trial group)
Publikováno v:
BMC Cancer
BMC Cancer, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, BioMed Central, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
BMC Cancer, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, BioMed Central, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Background Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trials to vali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b489f553d5abce5b605db53daf00b9
https://hal.sorbonne-universite.fr/hal-01980063/document
https://hal.sorbonne-universite.fr/hal-01980063/document